Log in to your Inderes Free account to see all free content on this page.

Ascelia Pharma

3.00 SEK

+2.04%

Less than 1K followers

ACE

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Ascelia Pharma

2019202020212022202320242025
Revenue
growth-%
EBITDA-36.8-93.4-137.9-147.0-110.9-67.8-74.4
EBIT-36.8-93.4-137.9-147.0-110.9-67.8-74.4
Profit before taxes-81.5-99.7-129.5-133.2-109.6-80.1-76.7
Net income-40.0-98.7-125.9-131.2-109.3-80.0-76.3
EPS-1.19-2.38-2.58-2.61-2.24-1.48-0.67
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %
Login required

This content is only available for logged in users

Profitability and return on capital

2019202020212022202320242025
EBITDA-%
EBIT-%
ROE-16.9 %-41.8 %-40.9 %-72.6 %-147.0 %-101.4 %-76.7 %
ROI-16.0 %-38.6 %-37.8 %-60.0 %-125.5 %-56.8 %-68.1 %
Login required

This content is only available for logged in users